drugset / Trial / NCT04202068

A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea

NCT04202068

Phase 4 Completed 113 enrolled Xiangbei Welman Pharmaceutical Co., Ltd
NaSingle-groupOpen-labelTreatment

Summary

This is a phaseIV, multicenter, open-label,single arm study which will be performed to evaluate efficacy and safety of Ceftriaxone sodium and Sulbactam Sodium for injection for the treatment of uncomplicated urogenital infection caused by Neisseria gonorrhoeae in adolescent and adult subjects.

Timeline

Start
2015-07-03
Primary completion
2016-05-03
Completion
2016-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftriaxone Other / unclassified Intravenous
Subject Sulbactam Small molecule Intravenous

Indications